https://www.marketscreener.com/quote/stock/LEXICON-PHARMACEUTICALS-I-22283344/news/Lexicon-Pharmaceuticals-Inc-Preparing-to-Resubmit-Sotagliflozin-NDA-for-Type-1-Diabetes-Following-F-46168978/?utm_source=telegram&utm_medium=social&utm_campaign=share